Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
IKT Inhibikase Therapeutics
0.640
+0.008+1.27%
Symbol
IKT
Company Name
Inhibikase Therapeutics
Listing Date
12/23/2020
Establishment Date
2008
CEO
Dr. Milton H. Werner, PhD
Market
NASDAQ
Employees
7
Securities Type
DR
Fiscal Year Ends
12-31
Address
3350 Riverwood Parkway,Suite 1900
City
Atlanta
Province
Georgia
Country
United States of America
Zip code
30339
Phone
1-678-392-3419
Profile
Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMP? Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
Company Overview
Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMP? Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
CEO: Dr. Milton H. Werner, PhD
Market: NASDAQ
Listing Date: 12/23/2020
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist